LIGAND PHARMACEUTICALS INCORPORATED Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) of $8.00 million as of 2012-01-31, per its 10-Q/A filed 2012-11-14.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationPotentialCashPayment · last filed 2012-11-14
- 2012-01-31: Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) $8.00M; Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) as first filed $6.00M.
| Period end | Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) | Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2012-01-31 | $8.00M 10-Q/A · filed 2012-11-14 | $6.00M 10-Q · filed 2012-08-08 |